Role of viral induced vascular endothelial growth factor (VEGF) production in pleural effusion and malignant mesothelioma

Cell Biology International

Volumn 33, Issue 2, 2009, Pages 180-186

  Wörnle, Markus ^a   Sauter, Matthias ^a   Kastenmüller, Kathrin ^a   Ribeiro, Andrea ^a   Roeder, Maximilian ^a   Mussack, Thomas ^a   Ladurner, Roland ^a   Sitter, Thomas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Malignant mesothelioma; MDA5; RIG I; Toll like receptor 3; VEGF

Indexed keywords

MDA5 PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS RNA;

ARTICLE; CALF (MAMMAL); DISEASE COURSE; DOSE RESPONSE; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; MESOTHELIUM; NUCLEOTIDE SEQUENCE; PLEURA EFFUSION; PROTEIN SYNTHESIS; VIRUS INDUCTION; VIRUS INFECTION;

EID: 58749111615     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.10.011     Document Type: Article

References (46)

1. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
2. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3. Nature 413 (2001) 732-738
3. Anders H.J., Banas B., and Schlöndorff D. Signalling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 15 (2004) 854-867
4. Astoul P. Pleural mesothelioma. Curr Opin Pulm Med 5 (1999) 259-268
5. Boussat S., Eddahibi S., Coste A., Fatacciolo V., Gouge M., Housset B., et al. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 279 (2000) 371-378
6. Brown L.F., Detmar M., Claffey K., Nagy J.A., Feng D., Dvorak A.M., et al. Vascular permeability factor/vascular endothelial growth factors: a multifunctional angiogenic cytokine. EXS 79 (1997) 233-269
7. Carbone M., Pass H.I., Rizzo P., Marinetti M., Di Muzio M., Mew D.J., et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9 (1994) 1781-1790
8. Cario E., and Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68 (2000) 7010-7017
9. Catalano A., Caprari P., Rodilossi S., Betta P., Castellucci M., Casazza A., et al. Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J 18 (2004) 358-360
10. Catalano A., Romano M., Martinotti S., and Procopio A. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. Oncogene 21 (2002) 2896-2900
11. Cheng D.S., Lee Y.C., Rogers J.T., Perkett E.A., Moyers J.P., Rodriguez R.M., et al. Vascular endothelial growth factor level correlates with transforming growth factor beta isoform levels in pleural effusions. Chest 118 (2000) 1747-1753
12. Cheng D., Rodriguez R.M., Perkett E.A., Rogers J., Bienvenu G., Lappalainen U., et al. Vascular endothelial growth factor in pleural fluid. Chest 116 (1999) 760-765
13. Clere N., Bermont L., Fauconnet S., Lascombe I., Saunier M., Vettoretti L., et al. The human papillomavirus type 18 E6 oncoprotein induces vascular endothelial growth factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism. Exp Cell Res 313 (2007) 3239-3250
14. Davidson B., Reich R., Lazarovici P., Florenes V.A., Risberg B., Nielsen S., et al. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma. Lung Cancer 44 (2004) 159-165
15. Filho A.L., Baltazar F., Bedrossian C., Michael C., and Schmitt F.C. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma. Diagn Cytopathol 35 (2007) 786-791
16. Grove C.S., and Lee Y.C. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 8 (2002) 294-301
17. Keck P.J., Hauser S.D., Krivi G., Sanzo K., Warren T., Feder J., et al. Vascular permeability factor, an endothelial mitogen related to PDGF. Science 246 (1989) 1309-1312
18. Kleinman M.E., Yamada K., Takeda A., Chandrasekaran V., Nozaki M., Baffi J.Z., et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452 (2008) 591-597
19. Koff J.L., Shao M.X., Ueki I.F., and Nadel J.A. Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol 294 (2008) 1068-1075
20. Kraft A., Weindel K., Ochs A., Marth C., Zmija J., Schumacher P., et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85 (1999) 178-187
21. Lee Y.C.G., and Lane K.B. The many faces of transforming growth factor beta in pleural diseases. Curr Opin Pulm Med 7 (2001) 173-179
22. Lee Y.C.G., Malkerneker D., Thompson P.J., Light R.W., Lane K.B., et al. Transforming growth factor-beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. Am J Respir Crit Care Med 165 (2002) 88-94
23. Le Goffic R., Pothlichet J., Vitour D., Fujita T., Meurs E., Chignard M., et al. Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 178 (2007) 3368-3372
24. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
25. Mack M., Kleinschmidt A., Brühl H., Klier C., Nelson, Cihak J., et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6 (2000) 769-775
26. Marshall-Clarke S., Downes J.E., Haga I.R., Bowie A.G., Borrow P., Pennock J.L., et al. Polyinosinic acid is a ligand for Toll-like receptor 3. J Biol Chem 282 (2007) 24759-24766
27. Matsukura S., Kokubu F., Kurokawa M., Kawaguchi M., Ieki K., Kuga H., et al. Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int Arch Allergy Immunol 143 (2007) 80-83
28. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 171 (2003) 3154-3162
29. Medzhitov R., and Janeway Jr. C.A. Innate immunity: the virtues of non-clonal system of recognition. Cell 91 (1997) 295-298
30. Mohammed K.A., Nasreen N., Hardwick J., Logie C.S., Patterson C.E., Antony V.B., et al. Bacterial induction of pleural mesothelial monolayer barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 281 (2001) 119-125
31. Mutsaers S.E. The mesothelial cell. Int J Biochem Cell Biol 36 (2004) 9-16
32. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z., et al. Vascular endothelial growth factor and its receptors. FASEB J 13 (1999) 9-22
33. Ohta Y., Shridhar V., Bright R.K., Kalemkerian G.P., Du W., Carbone M., et al. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer 81 (1999) 54-61
34. Ordonez N.G. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 36 (2005) 372-380
35. Roggli V.L., Sanfilippo F., and Shelburne J.D. Mesothelioma. In: Roggli V.L., Greenberg S.D., and Pratt P.C. (Eds). Pathology of asbestos-associated diseases (1992), Little, Brown and Co., Boston 109-164
36. Salcedo X., Medina J., Sanz-Cameno P., García-Buey L., Martín-Vilchez S., Borque M.J., et al. The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology 42 (2005) 696-701
37. Strizzi L., Catalano A., Vianale G., Orecchia S., Casalini A., Tassi G., et al. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol 193 (2001) 468-475
38. van Hinsbergh V.W., Kooistra T., Scheffer M.A., Hajo van Bockel J., and van Muijen G.N. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 75 (1990) 1490-1497
39. Verheul H.M.W., Hoekman K., Jorna A.S., Smit E.F., Pinedo H.M., et al. Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation. Oncologist 5 (2000) 45-50
40. Vitour D., and Meurs E.F. Regulation of interferon production by RIG-I and LGP2: a lesson in self-control. Sci STKE 384 (2007) 20
41. Whitaker D., Papadimitriou J.M., and Wlaters M.N. The mesothelium: its fibrinolytic properties. J Pathol 136 (1982) 291-299
42. Wörnle M., Schmid H., Banas B., Merkle M., Henger A., Roeder M., et al. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168 (2006) 370-385
43. Yanagawa H., Takeuchi E., Suzuki Y., Ohmoto Y., Bando H., Sone S., et al. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer. Cancer Immunol Immunother 48 (1999) 396-400
44. Yeo K.-T., Wang H.H., Nagy J.A., Sioussat T.M., Ledbetter S.R., Hoogewerf A.J., et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53 (1993) 2912-2918
45. Yount J.S., Moran T.M., and Lopet C.B. Cytokine-independent upregulation of MDA5 in viral infection. J Virol 81 (2007) 7316-7319
46. Zachary I. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol 280 (2001) 1375-1386